Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Accumulated Expenses (2024 - 2025)

Historic Accumulated Expenses for Pyxis Oncology (PYXS) over the last 2 years, with Q3 2025 value amounting to $8.0 million.

  • Pyxis Oncology's Accumulated Expenses fell 4311.73% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year decrease of 4311.73%. This contributed to the annual value of $11.4 million for FY2024, which is N/A changed from last year.
  • Pyxis Oncology's Accumulated Expenses amounted to $8.0 million in Q3 2025, which was down 4311.73% from $6.7 million recorded in Q2 2025.
  • In the past 5 years, Pyxis Oncology's Accumulated Expenses ranged from a high of $14.1 million in Q3 2024 and a low of $6.7 million during Q2 2025